Symptom phenotypes and coronary microvascular function in non-obstructive coronary artery disease: Insights beyond

Kotaro Matsumoto1, Kenichiro Otsuka1, Shunsuke Kagawa1

  • 1Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahicho, Abenoku, Osaka, 545-8585, Japan.

Insights

Coronary microvascular dysfunction (CMD) varies with chest pain symptoms in non-obstructive coronary artery disease (NOCA). Objective physiological testing is crucial for accurate CMD assessment, as symptoms alone are unreliable.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Non-obstructive coronary artery disease (NOCA) affects a significant patient population.
  • Coronary microvascular dysfunction (CMD) is increasingly recognized as a cause of angina in NOCA.
  • Current diagnostic approaches often rely on symptom presentation, which may not accurately reflect underlying physiology.

Purpose of the Study:

  • To investigate the relationship between coronary microvascular dysfunction (CMD) indices and chest pain presentation in patients with NOCA.
  • To assess the diagnostic performance of symptom-based evaluation for detecting CMD.
  • To determine if objective physiological measures correlate with symptom severity in NOCA patients.

Main Methods:

  • Retrospective observational study of 59 patients with intermediate LAD stenosis and preserved FFR.
  • Invasive assessment of coronary microvascular function using coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and myocardial resistance reserve (MRR).
  • Analysis of associations between symptom phenotypes (typical angina, atypical, asymptomatic) and physiological indices.

Main Results:

  • Coronary flow reserve (CFR) and myocardial resistance reserve (MRR) significantly differed across symptom phenotypes (p < 0.001), with typical angina patients showing the lowest values.
  • Index of microcirculatory resistance (IMR) did not differ significantly between groups.
  • Symptom severity inversely correlated with CFR and MRR (p < 0.005), and symptom-based assessment demonstrated higher specificity than sensitivity for CMD detection.

Conclusions:

  • Coronary microvascular vasodilatory reserve varies significantly based on symptom presentation in NOCA patients.
  • Symptom assessment alone is unreliable for diagnosing CMD in NOCA.
  • Objective physiological evaluation is essential for accurate characterization and management of CMD in NOCA.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K